
© Amphista Therapeutics
All rights reserved
Useful links
Address
BioCity, Bo'Ness Rd, Newhouse, Chapelhall, Motherwell, ML1 5UH, UK
Registered Address
158-160 North Gower Street, London, NW1 2ND, UK
Contact: info@amphista.com
Website by FisherPaul
Eli Lilly, Novartis back a biotech startup boasting ‘best of both worlds’ protein degraders
/in In the news /by ginealachThis article was sourced from Endpoints. Since heading up GlaxoSmithKline’s protein degradation unit in 2012, Ian Churcher has witnessed a rapid explosion of interest in the idea of leveraging the body’s garbage disposal system to eliminate problematic proteins. Huge amounts of money are flowing in from biotech VCs and Big Pharma players, bankrolling a huge […]
Amphista Therapeutics Is Silencing Disease Proteins to Treat Cancer
/in In the news /by ginealachThis article was sourced from La Biotech. Amphista Therapeutics, based in Glasgow, Scotland, is the latest company to develop drugs called PROTACs, which are designed to make the cell degrade harmful proteins to treat cancer. Small molecule drugs have shown incredible potential for the treatment of cancer by blocking harmful proteins in the cell. However, […]